Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$8.93 – $12.99
44% from low
Exchange
OTC Link
ADRC
Borrow rate
0.70%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.43T | $2.19T | $2.19T | $2.53T | $2.86T | $2.96T | $3.20T | $3.56T |
| Cost of revenue | $1.43T | $1.32T | $1.49T | $1.49T | $1.72T | $1.77T | $1.90T | $2.11T |
| Gross profit | $997.52B | $869.69B | $1.03T | $1.03T | $1.14T | $1.19T | $1.30T | $1.45T |
| Gross margin | 41.0% | 39.7% | 47.1% | 40.9% | 39.8% | 40.1% | 40.7% | 40.8% |
| R&D | $156.13B | $152.15B | $150.53B | $150.53B | $154.15B | $157.11B | $163.40B | $167.31B |
| Operating income | $209.83B | $165.47B | $165.47B | $229.70B | $273.08B | $276.73B | $330.15B | $371.33B |
| EBITDA | $346.01B | $313.09B | $361.87B | $395.76B | $429.44B | $475.79B | $512.91B | $554.10B |
| Net income | $138.11B | $181.21B | $181.21B | $211.18B | $219.42B | $243.51B | $260.95B | $293.42B |
| Net margin | 5.7% | 8.3% | 8.3% | 8.4% | 7.7% | 8.2% | 8.2% | 8.2% |
| EPS (diluted) | 162.91 | 220.97 | 75.29 | 87.69 | 45.56 | 101.03 | 108.23 | 121.44 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $3.56T | $119.63 | $118.03–$124.38 | 1 |
| 2028 | $3.73T | $136.42 | $131.87–$141.84 | 1 |
| 2029 | $3.88T | $152.45 | $147.37–$158.52 | 1 |
| 2030 | $4.11T | $160.00 | $154.67–$166.36 | 1 |
Forward consensus · source: Financial Modeling Prep
FUJIFILM HLDGS CORP ADR
No one on the platform currently holds FUJIY.
No tracked institution reports a position in FUJIY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-04-02 | 6-for-1 |
No one on the platform has traded FUJIY yet.
| -6.47% |
| $23.3B |
| — |
| EJPRYEast Japan Railway Company | $10.36 | -2.17% | $23.4B | — |
| ICAGYInternational Consolidated Airlines Group S.A. | $12.60 | -0.45% | $28.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× earnings vs its 0.1× historical median P/E.
Fair value ≈ $11.86 · price $10.70 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$FUJIY - Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. - $ICEL
View on StockTwits ↗FDA issues alert re: ERCP endoscopes (Major Supplier: $OCPNY $FUJIY) associated with "superbug" fast-track new lables http://stks.co/j1qpt
View on StockTwits ↗FUJIFILM Holdings Corp. (ADR) announces earnings. $0.93 EPS. $FUJIY http://stks.co/t1Me1
View on StockTwits ↗I'm definetely buying some $FUJIY this week
View on StockTwits ↗All you $IBIO share holders should also think about $FUJIY
View on StockTwits ↗Fujifilm $FUJIY Expects Ebola Drug Approval By Year-End http://stks.co/i1I5p
View on StockTwits ↗Ebola Contracts Worth $2 Billion To Benefit Pharma Companies http://stks.co/f1IHV $ABUS $CMRX $FUJIY $EBS $LUMO
View on StockTwits ↗Drug makers working on developing preventive vaccines and cures - http://stks.co/f1ICl $ABUS $CMRX $FUJIY $EBS $LUMO
View on StockTwits ↗$FUJIY Will Fujifilm (FUJIY) Stock Be Affected Today by This Analyst Action? http://stks.co/a1CkZ
View on StockTwits ↗$FUJIY FUJIFILM (FUJIY) Stock Higher Today on Kalon Purchase http://stks.co/f1Di8
View on StockTwits ↗Fujifilm has decided to maximize its potential in finding an Ebola cure - http://stks.co/e1AU8 $FUJIY
View on StockTwits ↗$FUJIY Fujifilm subsidiary working on flu drug that could be used for Ebola http://stks.co/g1C6l
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.